Ultragenyx buys gene therapy partner after new study results
Novartis looking for new homes for midphase asthma, eye disease and NASH assets after pipeline review
Innovent & Eli Lilly's type 2 diabetes drug lowers HbA1c, scores early win
Merck to stop Phase 3 trial of Lynparza drug in colorectal cancer
*please scroll down for all the latest news*
